1
|
Craig JK, Risler JK, Loesch KA, Dong W, Baker D, Barrett LK, Subramanian S, Samudrala R, Van Voorhis WC. Mycobacterium Cytidylate Kinase Appears to Be an Undruggable Target. JOURNAL OF BIOMOLECULAR SCREENING 2016; 21:695-700. [PMID: 27146385 PMCID: PMC8565994 DOI: 10.1177/1087057116646702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/30/2015] [Accepted: 04/05/2016] [Indexed: 11/17/2022]
Abstract
New and improved drugs against tuberculosis are urgently needed as multi-drug-resistant forms of the disease become more prevalent. Mycobacterium tuberculosis cytidylate kinase is an attractive target for screening due to its essentiality and different substrate specificity to the human orthologue. However, we selected the Mycobacterium smegmatis cytidylate kinase for screening because of the availability of high-resolution X-ray crystallographic data defining its structure and the high likelihood of active site structural similarity to the M. tuberculosis orthologue. We report the development and implementation of a high-throughput luciferase-based activity assay and screening of 19,920 compounds derived from small-molecule libraries and an in silico screen predicting likely inhibitors of the cytidylate kinase enzyme. Hit validation included a counterscreen for luciferase inhibitors that would result in false positives in the initial screen. Results of this counterscreen ruled out all of the putative cytidylate kinase inhibitors identified in the initial screening, leaving no compounds as candidates for drug development. Although a negative result, this study indicates that this important drug target may in fact be undruggable and serve as a warning for future investigations.
Collapse
Affiliation(s)
- Justin K Craig
- Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Seattle, WA, USA
| | - Jenni K Risler
- Fred Hutchinson Cancer Research Center (Fred Hutch), Genomics Shared Resource, High-Throughput Screening Facility, Seattle, WA, USA
| | - Kimberly A Loesch
- Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX, USA
| | - Wen Dong
- Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX, USA
| | - Dwight Baker
- Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX, USA
| | - Lynn K Barrett
- Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Seattle, WA, USA
| | | | - Ram Samudrala
- Department of Biomedical Informatics, University of Buffalo, State University of New York, Buffalo, NY, USA
| | - Wesley C Van Voorhis
- Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Seattle, WA, USA Departments of Global Health and Microbiology, University of Washington, Seattle, WA, USA
| |
Collapse
|